The global topical antibiotic pharmaceuticals market is expected to grow at a CAGR of 4.5% during the forecast period, to reach USD 3.2 billion by 2030. The growth of this market is driven by the increasing prevalence of skin infections and rising demand for topical antibiotics from hospitals and clinics.
The global topical antibiotic pharmaceuticals market is segmented on the basis of type, application, and region. On the basis of type, it is classified into ointment, cream, suspension, powder; on the basis of application it includes hospitals & clinics (private), retail pharmacies & drug stores (private), retail pharmacies & drug stores (public); on the basis of region it includes North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa(MEA).
- The increasing number of people with chronic diseases such as diabetes and asthma is driving the demand for antibiotics.
- The growing number of antibiotic-resistant bacteria strains is also driving the demand for new antibiotics.
- The increasing global population, which will lead to an increase in the incidence of infectious diseases, will also drive the demand for new antibiotics.
- Increasing awareness about antibiotic resistance and its consequences among healthcare professionals and patients is leading to increased prescriptions for antibiotics.
- Increasing research on novel drug targets by pharmaceutical companies.
Industry Growth Insights published a new data on “Topical Antibiotic Pharmaceuticals Market”. The research report is titled “Topical Antibiotic Pharmaceuticals Market research by Types (Ointment, Cream, Suspension, Powder), By Applications (Hospitals Clinics, Private Clinics, Retail Pharmacies and Drug Stores, E-commerce), By Players/Companies Teva Pharmaceutical Industries, Perrigo, Taro Pharmaceutical Industries, Pfizer, Glenmark Pharmaceuticals, GlaxoSmithKline, Fera and Watson pharmaceuticals”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Topical Antibiotic Pharmaceuticals Market Research Report
By Type
Ointment, Cream, Suspension, Powder
By Application
Hospitals Clinics, Private Clinics, Retail Pharmacies and Drug Stores, E-commerce
By Companies
Teva Pharmaceutical Industries, Perrigo, Taro Pharmaceutical Industries, Pfizer, Glenmark Pharmaceuticals, GlaxoSmithKline, Fera and Watson pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Topical Antibiotic Pharmaceuticals Market Report Segments:
The global Topical Antibiotic Pharmaceuticals market is segmented on the basis of:
Types
Ointment, Cream, Suspension, Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals Clinics, Private Clinics, Retail Pharmacies and Drug Stores, E-commerce
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva Pharmaceutical Industries
- Perrigo
- Taro Pharmaceutical Industries
- Pfizer
- Glenmark Pharmaceuticals
- GlaxoSmithKline
- Fera and Watson pharmaceuticals
Highlights of The Topical Antibiotic Pharmaceuticals Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ointment
- Cream
- Suspension
- Powder
- By Application:
- Hospitals Clinics
- Private Clinics
- Retail Pharmacies and Drug Stores
- E-commerce
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Topical Antibiotic Pharmaceuticals Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Topical antibiotic pharmaceuticals are medications that are applied to the skin. They are used to treat infections, such as acne, eczema, and psoriasis.
Some of the major companies in the topical antibiotic pharmaceuticals market are Teva Pharmaceutical Industries, Perrigo, Taro Pharmaceutical Industries, Pfizer, Glenmark Pharmaceuticals, GlaxoSmithKline, Fera and Watson pharmaceuticals.
The topical antibiotic pharmaceuticals market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Topical Antibiotic Pharmaceuticals Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Topical Antibiotic Pharmaceuticals Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Topical Antibiotic Pharmaceuticals Market - Supply Chain
4.5. Global Topical Antibiotic Pharmaceuticals Market Forecast
4.5.1. Topical Antibiotic Pharmaceuticals Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Topical Antibiotic Pharmaceuticals Market Size (000 Units) and Y-o-Y Growth
4.5.3. Topical Antibiotic Pharmaceuticals Market Absolute $ Opportunity
5. Global Topical Antibiotic Pharmaceuticals Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Type
5.3.1. Ointment
5.3.2. Cream
5.3.3. Suspension
5.3.4. Powder
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Topical Antibiotic Pharmaceuticals Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Application
6.3.1. Hospitals Clinics
6.3.2. Private Clinics
6.3.3. Retail Pharmacies and Drug Stores
6.3.4. E-commerce
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Topical Antibiotic Pharmaceuticals Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Topical Antibiotic Pharmaceuticals Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Topical Antibiotic Pharmaceuticals Demand Share Forecast, 2019-2026
9. North America Topical Antibiotic Pharmaceuticals Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Application
9.4.1. Hospitals Clinics
9.4.2. Private Clinics
9.4.3. Retail Pharmacies and Drug Stores
9.4.4. E-commerce
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Type
9.7.1. Ointment
9.7.2. Cream
9.7.3. Suspension
9.7.4. Powder
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Topical Antibiotic Pharmaceuticals Demand Share Forecast, 2019-2026
10. Latin America Topical Antibiotic Pharmaceuticals Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Application
10.4.1. Hospitals Clinics
10.4.2. Private Clinics
10.4.3. Retail Pharmacies and Drug Stores
10.4.4. E-commerce
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Type
10.7.1. Ointment
10.7.2. Cream
10.7.3. Suspension
10.7.4. Powder
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Topical Antibiotic Pharmaceuticals Demand Share Forecast, 2019-2026
11. Europe Topical Antibiotic Pharmaceuticals Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Application
11.4.1. Hospitals Clinics
11.4.2. Private Clinics
11.4.3. Retail Pharmacies and Drug Stores
11.4.4. E-commerce
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Type
11.7.1. Ointmen
11.7.2. Cream
11.7.3. Suspension
11.7.4. Powder
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Topical Antibiotic Pharmaceuticals Demand Share, 2019-2026
12. Asia Pacific Topical Antibiotic Pharmaceuticals Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Application
12.4.1. Hospitals Clinics
12.4.2. Private Clinics
12.4.3. Retail Pharmacies and Drug Stores
12.4.4. E-commerce
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Type
12.7.1. Ointment
12.7.2. Cream
12.7.3. Suspension
12.7.4. Powder
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Topical Antibiotic Pharmaceuticals Demand Share, 2019-2026
13. Middle East & Africa Topical Antibiotic Pharmaceuticals Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Application
13.4.1. Hospitals Clinics
13.4.2. Private Clinics
13.4.3. Retail Pharmacies and Drug Stores
13.4.4. E-commerce
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Topical Antibiotic Pharmaceuticals Market Size and Volume Forecast by Type
13.7.1. Ointment
13.7.2. Cream
13.7.3. Suspension
13.7.4. Powder
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Topical Antibiotic Pharmaceuticals Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Topical Antibiotic Pharmaceuticals Market: Market Share Analysis
14.2. Topical Antibiotic Pharmaceuticals Distributors and Customers
14.3. Topical Antibiotic Pharmaceuticals Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Teva Pharmaceutical Industries
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Perrigo
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Taro Pharmaceutical Industries
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pfizer
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Glenmark Pharmaceuticals
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GlaxoSmithKline
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Fera and Watson pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
